Novartis Investigative Site

Bangkok, THA 10330

0 studies enrolling now · 5 studies all time

What they study most

Acute Myocardial Infarction, Advanced NET of GI Origin, Advanced NET of Lung Origin, Cushing's Disease, Neuroendocrine Tumors, Non-Small Cell Lung Cancer, Rheumatoid Arthritis

Studies at this site

• Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI — Completed
• Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) — Completed
• Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease — Completed
• Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin) — Completed
• Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents — Completed